期刊文献+

专项整治前后社区获得性肺炎患者抗菌药物应用分析 被引量:3

Analysis of Antibacterials Use in Patients with Community-acquired Pneumonia before and after Special Rectification
原文传递
导出
摘要 目的:调查抗菌药物专项整治前、后某院社区获得性肺炎(CAP)住院患者抗菌药物的应用情况。方法:采用回顾性方法,查阅2011年6月(整治前)和2012年6月(整治后)某院住院CAP患者的出院病历,对抗菌药物的应用情况进行统计、分析。结果:整治后该院CAP患者平均住院时间由14.54d缩短至12.44d;平均抗菌药物疗程由18.00d缩短到12.67d;抗菌药物的使用强度(AUD)由154.43DDDs/100人/天下降到111.58DDDs/100人/天(P<0.01);抗菌药物平均费用由2690.31元下降至1666.96元(P<0.01);患者出院带药由31例次减少到12例次(P<0.01)。但在指标下降的同时,不按CAP指南选择药物治疗的问题仍然突出。结论:开展专项整治有助于促进抗菌药物应用管理;但医疗机构在控制指标的同时,尚需加强对抗菌药物临床应用合理性的评价。 OBJECTIVE:To investigate the clinical application of antibacterials in hospitalized patients with community-acquired pneumonia (CAP) before and after special rectification.METHODS:By retrospective study,discharged medical records of CAP patients in a hospital were reviewed in Jun.2011 (before special rectification) and Jun.2012 (after special rectification).The use of antibacterials was analyzed statistically.RESULTS:After special rectification,the average hospitalization days of CAP patients was shortened from 14.54 d to 12.44 d;the average duration of antibacterials was shortened from 18.00 d to 12.67 d;AUD decreased from 154.43 DDDs/100 persons/day to 111.58 DDDs/100 persons/day (P&lt;0.01);the average cost of antibacterials was decreased from 2 690.31 yuan to 1 666.96 yuan (P&lt;0.01);and the number of discharge medication was decreased from 31 cases to 12 cases(P&lt;0.01).While the indicators fell,the problem of drug selection which didn’t followed the guidelines was still outstanding.CONCLUSIONS:The special rectification helps to promote the use and management of antibacterials.However,medical institutions control indicators,at the same time need to strengthen the evaluation of rationality of antibacterials use.
出处 《中国药房》 CAS CSCD 2013年第30期2803-2806,共4页 China Pharmacy
关键词 抗菌药物 专项整治 社区获得性肺炎 经验性治疗 Antibacterials Special rectification Community-acquired pneumonia Empirical treatment
  • 相关文献

参考文献8

二级参考文献101

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2罗文侗.社区获得性肺炎的抗菌治疗进展[J].中国临床药学杂志,2006,15(1):1-4. 被引量:20
  • 3刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:789
  • 4社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3065
  • 5Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 6Lepow ML,Balassanian N,Emmerich J,et al.Interrelationships of viral,mycoplasmal,and bacterial agents in uncomplicated pneumonia.Am Rev Respir Dis,1968,97:533-545.
  • 7Lim WS,Macfarlane JT,Boswell TC,et al.Study of community acquired pneumonia aetiology(SCAPA) in adults admitted to hospital:implications for management guidelines.Thorax,2001,56:296-301.
  • 8Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754.
  • 9Heffelfinger JD,Dowell SF,Jorgensen JH,et al.Management of community-acquired pneumonia in the era of pneumococcal resistance:a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.Arch Intern Med,2000,160:1399-1408.
  • 10Bartlett JG,Dowell SF,Mandell LA,et al.Practice guidelines for the management of community-acquired pneumonia in adults[J].Clin Infect Dis,2000,31(2):422-425.

共引文献3652

同被引文献24

引证文献3

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部